Related Experiment Video
Updated: Mar 23, 2026
04:01
Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
Published on: March 15, 2024
2.1K
Mechanisms of ferroptosis
Jennifer Yinuo Cao1, Scott J Dixon2
1Department of Biology, Stanford University, 337 Campus Dr., Stanford, CA, 94305, USA.
Cellular and Molecular Life Sciences : CMLS
|April 7, 2016
Summary
Ferroptosis, a cell death pathway driven by iron and lipid oxidation, can be triggered by inhibiting glutathione peroxidase 4 (GPX4). Inhibitors like ferrostatin-1 offer therapeutic potential.
Area of Science:
- Biochemistry
- Cell Biology
- Oncology
Background:
- Ferroptosis is a non-apoptotic cell death characterized by iron-dependent lipid peroxidation.
- It can be induced by inhibiting glutathione biosynthesis or glutathione peroxidase 4 (GPX4).
- Certain cancer cells with specific genetic profiles may be vulnerable to ferroptosis.
Purpose of the Study:
- To summarize the key features of ferroptosis.
- To highlight its regulation by metabolic pathways and genetic factors.
- To discuss the therapeutic potential of modulating ferroptosis.
Main Methods:
- Literature review of ferroptosis mechanisms and regulators.
- Analysis of genes involved in lipid and amino acid metabolism.
- Examination of small molecule inhibitors of ferroptosis.
Main Results:
- Ferroptosis involves the accumulation of lipid reactive oxygen species and depletion of polyunsaturated fatty acids.
- Genes in lipid and amino acid metabolism are crucial for ferroptosis.
- Small molecules like ferrostatin-1 and liproxstatin-1 inhibit ferroptosis and protect tissues.
Conclusions:
- Ferroptosis is a distinct cell death pathway with implications for cancer therapy.
- Understanding ferroptosis's relationship with other cell death forms is crucial.
- Targeting ferroptosis presents potential therapeutic strategies for various diseases.
Related Concept Videos
01:16Necrosis
7.2K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
7.2K
01:30Overview of Cell Death
11.0K
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
11.0K
01:30The Electron Transport Chain
21.2K
The electron transport chain or oxidative phosphorylation is an exothermic process in which free energy released during electron transfer reactions is coupled to ATP synthesis. This process is a significant source of energy in aerobic cells, and therefore inhibitors of the electron transport chain can be detrimental to the cell's metabolic processes.
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
21.2K
01:28The Early Endosome: Endocytosis of Transferrin
5.1K
Essential proteins such as insulin or low-density lipoprotein (LDL) and micronutrients such as iron enter a eukaryotic cell through receptor-mediated endocytosis. Subsequently, the early endosomes fuse with the vesicles containing such receptor-ligand complexes and play a vital role in sorting the incoming ligands and receptors. While the ligands are either degraded inside the vesicle or released into the cytosol, their receptors are returned to the plasma membrane for further rounds of...
5.1K
01:46Electron Transport Chain: Complex I and II
19.5K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
19.5K
01:43Electron Transport Chain: Complex III and IV
9.7K
During the electron transport chain, electrons from NADH and FADH2 are first transferred to complexes I and II, respectively. These two complexes then transfer the electrons to ubiquinol, which carries them further to complex III. Complex III passes the electrons across the intermembrane space to Cyt c, which carries them further to complex IV. Complex IV donates electrons to oxygen and reduces it to water. As electrons pass through complexes I, III, and IV, the energy released aids the pumping...
9.7K